Federal pharmacist Paxlovid prescribing authority: A model policy or impediment to optimal care?
Description
The U.S federal government leveraged emergency authority to allow pharmacists to prescribe Paxlovid (nirmatrelvir and ritonavir) during the COVID-19 pandemic. While heralded by pharmacy associations, the FDA framework included restrictions that
